This platform provides licensed prescribers with access to oral peptide and GLP-1 delivery education, clinical frameworks, and supporting resources built around Advanced Micronized Chelation Technology (AMCT™).

AMCT™ is designed to expand what is clinically feasible with oral peptides—supporting consistent exposure, simplified administration, and improved long-term adherence—while preserving prescriber oversight and regulatory alignment.

AMCT™ is a next-generation oral delivery platform engineered to enable peptides traditionally limited to injection to be delivered in potent, stable, orally disintegrating or protected oral formats.

Rather than relying on gastric disruption or brute-force dosing, AMCT™ utilizes a physiologically aligned, multi-stage delivery architecture intended to:

  • Protect peptides from enzymatic degradation
  • Support targeted epithelial transport
  • Enable efficient uptake at substantially lower daily doses

For prescribers, this translates to more predictable oral exposure without strict fasting requirements or injection burden.

Detailed mechanistic data and observational findings are available in the AMCT™ White Paper.

Molecular Encapsulation
Peptides are stabilized within protective carriers designed to resist breakdown during transit.

Targeted Transport
Formulation strategies support peptide passage across absorptive surfaces without disrupting normal GI physiology.

High-Efficiency Uptake
Controlled release supports consistent systemic exposure with reduced variability.

Within this platform, you’ll find access to:

All materials are intended for professional use by licensed prescribers and are not patient-facing.

AMCT™ delivery technology and associated protocols are implemented exclusively through licensed prescribers and regulated pharmacy partners.

Educational material only.
No medical claims.
Clinical decisions remain the responsibility of the prescribing clinician.

Menu